Compare Moderna, Inc. (MRNA) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Nuscale Power Corporation — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Nuscale Power Corporation trades at $8.81 (market cap $2.76B). The key difference: Moderna, Inc. is far larger — about 8.6× Nuscale Power Corporation's market cap, and Moderna, Inc. is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| MRNA | SMR | |
|---|---|---|
Market Cap | $23.60B | $2.76B |
Sector | Health | Utilities |
52-Week High | $81.80 | $53.43 |
52-Week Low | $22.36 | $7.64 |
Enterprise Value | $19.70B | $1.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
